Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04648267
Other study ID # HS-20-00490
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 5, 2021
Est. completion date November 30, 2025

Study information

Verified date May 2024
Source University of Southern California
Contact Liyang Tang
Phone 1-800-USC-CARES
Email liyang.tang@med.usc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Fibula free flaps (FFF) and radial forearm free flaps (RFFF) are necessary to reconstruct parts of the face after cancer surgery, traumas, or debilitating infections. Oftentimes, after we take the flap from the arm or leg, there is a large skin defect that must be filled. A split thickness skin graft (STSG) usually from the thigh can be used to fill this defect. Split thickness skin grafts get their blood supply from the underlying tissue, Hence, pressure must be applied to the skin grafts to ensure that they "stick" to the underlying tissue and are properly perfused. A bolster and cast is placed onto the skin graft to apply pressure and to immobilize the skin graft to optimize healing. However, skin grafts still often do not take well. Thus, the objective of this study is to see if the duration of the cast and bolster over the skin graft has an effect on how well it integrates into the wound bed. The study will compare 2 groups: the standard of care 5-7 day cast group versus the experiment 10-14 day cast group. The hypothesis is that people with longer cast and bolster duration will have better healing rates. Surveys will also be administered to see if cast and bolster duration will affect quality of life and self-esteem.


Description:

This will be a prospective randomized control trial with a recruitment goal of 220 patients. One hundred and ten (110) patients will have undergone a split thickness skin graft (STSG) to reconstruct the fibula free flap (FFF) donor site and another one hundred and ten (110) patients will be for those with a radial forearm free flap (RFFF) donor site. This is anticipated to be a 5 year study. Patients will be recruited in clinic. The study will be discussed at their pre-surgery evaluation visit and patients will be provided with a copy of the consent form to take home to discuss whether or not they wish to proceed with the study. On the day of the surgery, should the patients decide on joining the study, they will be consented and asked to fill out pre-surgery surveys. These surveys are the quality of life 36 item short form survey (SF 36) and a Rosenberg self-esteem survey. Participants will be randomized to either the standard or the experimental group and this information will be placed in an opaque envelope attached to the consent. Participants then undergo surgery and receive routine post-operative care as per standard of care. After surgery on post operative day 1, one of the co-investigators will open the envelope which will reveal whether the participant is to have the cast and bolster for 5-7 days or 10-14 days. Participants who have their casts and bolsters on for 5-7 days will have them removed before discharge and those who are assigned to the longer group will have them taken off in clinic at their first post-operative visit. At their one month follow up appointment, a picture will be taken of the donor site. Participants will also be asked to fill out a quality of life 36 item short form survey (SF 36) and a Rosenberg self-esteem survey directly on Redcap. Participants do not have to make extra trips to the physician's office. These pictures and surveys will be administered at their routine office visits. At 3 month, the participant will receive the same surveys again by mail or email, per their preference. Once they have completed these surveys at 3 months, they will have completed their portion of the study. The investigators will then analyze the skin graft pictures on Adobe Photoshop. All of the photos of the grafts will be de-identified and the people analyzing the pictures will be blinded. They will estimate the percentage of the graft that has healed well or "take"


Recruitment information / eligibility

Status Recruiting
Enrollment 220
Est. completion date November 30, 2025
Est. primary completion date November 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients who underwent a radial forearm free flap or fibula free flap and split thickness skin graft placed over the donor site Exclusion Criteria: - Patients who cannot make informed decisions - Patients who cannot make their one month post-operative appointment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cast and bolster placement duration
The intervention is increasing the duration of cast and bolster placement on split thickness skin graft sites.
Standard of care
This will be standard of care - the patient will have his cast and bolster on for 5-7 days

Locations

Country Name City State
United States University of Southern California Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
University of Southern California

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The effect of cast and bolster duration on split thickness skin graft integration At one month, we will take pictures in clinic of the split thickness skin graft. Afterwards, two blinded investigators will determine how much of the skin graft has integrated. Exposed tendon and muscle indicate that that part of the skin graft has failed. This will be done on Adobe Photoshop and the integration percentage will be scored. The scale will be from 0% to 100%. A higher percentage is a better outcome The patient will be assessed one month after surgery to take a picture of their skin grafts.
Secondary The effect of cast duration on self esteem The surveys that will be administered include the Rosenberg self-esteem survey. This is scored on a 4 point Likert scale. A higher score indicates higher self-esteem and a more favorable outcome The surveys will be administered once before surgery, once 1 month after surgery and once 3 months after surgery
Secondary The effect of cast duration on quality of life The surveys that will be administered include the Short Form 36 quality of life form (SF 36). It is measured with 8 scales scores. Each scale is then transformed into a percentage from 0 to 100. A higher percentage indicates less disability and a more favorable outcome The surveys will be administered once before surgery, once 1 month after surgery and once 3 months after surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06134843 - Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds Phase 1/Phase 2
Withdrawn NCT02994589 - A Comparison of OASIS Wound Matrix With Approved Dressings for Skin Graft Donor Sites Phase 4
Terminated NCT03937765 - The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites N/A
Not yet recruiting NCT05367726 - The Contributions of the Multidisciplinary Management of Prosthesis Knee Infections in a Reference Center: A Retrospective Study About 52 Cases.Skin Coverage in a Reference Center: A Retrospective Study About 52 Cases
Not yet recruiting NCT06379724 - Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft Phase 4
Terminated NCT04014400 - Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites N/A
Withdrawn NCT03548610 - Efficacy and Safety of a Nanofat-seeded Biological Scaffold in Healing Lower Limb Surgical Defects N/A
Completed NCT04231305 - Antithrombotics and Complications in Skin Grafts
Recruiting NCT05447793 - Effectiveness and Tolerability of Fitostimoline Plus vs Connettivina Bio Plus in Skin Graft
Completed NCT06170424 - Retrospective Analysis of Spray Skin Treats for Severe Burns
Recruiting NCT04186273 - Clinical Safety and Scar Prevention Study of a Topical Antifibrotic Compound FS2. Phase 2